| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/22/2004 | US20040014662 Modulation of neural stem cells and neural progenitor cells |
| 01/22/2004 | US20040014660 Insulin-associated peptides with effects on cerebral health |
| 01/22/2004 | US20040014657 Use of blood coagulation factor XIII for treating haemophilia A |
| 01/22/2004 | US20040014656 Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency |
| 01/22/2004 | US20040014655 Pharmaceutical compositions containing plasma protein |
| 01/22/2004 | US20040014654 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 01/22/2004 | US20040014653 Oral diseases; skin disorders; aging resistance |
| 01/22/2004 | US20040014651 Treating the effects of nicotine |
| 01/22/2004 | US20040014650 Prevent hemostasis; controlling immunology response; administering adipocyte to mammals; wound healing agent |
| 01/22/2004 | US20040014649 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014647 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them |
| 01/22/2004 | US20040014646 Antibiotics AW998A, AW998B, AW998C and AW998D |
| 01/22/2004 | US20040014643 Method of structure-based drug design to create or improve modular of IL-1 activity which mind to the interleukin-1 type 1 receptor |
| 01/22/2004 | US20040014641 Mammalion haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof |
| 01/22/2004 | US20040014640 Composition for diminishing neutral fat in blood |
| 01/22/2004 | US20040014639 Adjust gene expression of adrenergic receptor; synergistic mixture with andrenergic antagonist; control metabolism of lipids, carbohydrates |
| 01/22/2004 | US20040014638 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014636 Pharmaceutical compositions comprising a modulator of adamts-1 |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014602 Using antibiotic |
| 01/22/2004 | US20040014207 Dendritic cell potentiation |
| 01/22/2004 | US20040014192 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/22/2004 | US20040014191 Comprises nucleotide sequences and viral vector coding nitroreductase for generating cytotoxic 4- hydroxylamine to treat cancer; site diredted mutagenesis; prodrugs; anticarcinogenic agents |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014173 Comprises proteins for diagnosis, prevention and/or treatment of cancer, inflammation, defective wound healing, skin, vision and blood disorders |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014149 Relates to compounds that modulate processes associated with isotype switching of B cells and IgE production; treatment of diseases characterized by production or accumulation of IgE, including anaphylactic hypersensitivity, allergic reactions |
| 01/22/2004 | US20040014143 Classification, separation and detection of neuropeptides; diagnosis and treatment of nervous system disorders |
| 01/22/2004 | US20040014141 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/22/2004 | US20040014136 Crystal structure of complement inhibitor (sCR1) for preventing hemolysis, necrosis and tissue destruction |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014121 Methionyl tRNA synthetase (metS) polypeptides and DNA (RNA) encoding them and methods for producing such polypeptides by recombinant techniques; utilizing metS polypeptides to screen for antibacterial compounds |
| 01/22/2004 | US20040014120 Novel proteins and nucleic acids encoding the same |
| 01/22/2004 | US20040014112 Novel human kinase proteins and polynucleotides encoding the same |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014093 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, Protease-42 |
| 01/22/2004 | US20040014089 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014053 Novel proteins and nucleic acids encoding same |
| 01/22/2004 | US20040014051 Antisense modulation of breast cancer-1 expression |
| 01/22/2004 | US20040014050 Antisense modulation of EDG8 expression |
| 01/22/2004 | US20040014049 Used for treatment of diseases associated with expression of protein kinase C-iota ; cancer |
| 01/22/2004 | US20040014048 Antisense modulation of dual specific phosphatase 6 expression |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014038 G-protein coupled receptor (GPCR) polypeptides, vectors, host cells, antibodies, and recombinant methods for producing nucleic acids/polypeptides; methods for diagnosis, treatment, and prevention of disorders involving these human proteins |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013728 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013707 Alertness bar |
| 01/22/2004 | US20040013692 Use of botulinum toxins for treating various disorders and conditions and associated pain |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013685 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 01/22/2004 | US20040013683 Polypeptide viricides; genetic engineering |
| 01/22/2004 | US20040013680 Neurotoxic oligomers |
| 01/22/2004 | US20040013679 LL-37 is an immunostimulant |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013674 Transdermal activator protein; antiproliferative agent; reducing solid tumors |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013665 Immunoreactive peptides from Epstein-Barr virus |
| 01/22/2004 | US20040013664 Antiinflamamtory agents; antiallergens; antihistamines |
| 01/22/2004 | US20040013662 Microbubble compositions and methods for oligonucleotide delivery |
| 01/22/2004 | US20040013661 Gene controlling peptide; antiinflammatory agents |
| 01/22/2004 | US20040013660 Synergistic mixtures |
| 01/22/2004 | US20040013659 Suspension of an EPI-hNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 01/22/2004 | US20040013658 Method of inducing apoptosis by reducing the level of thiamin |
| 01/22/2004 | US20040013657 Novel nucleic acids and polypeptides |
| 01/22/2004 | US20040013655 Mutant Dna; transcription of genomes |
| 01/22/2004 | US20040013650 Adjust concentration of circulating genes; in situ transformation of muscle by injecting virus vector |
| 01/22/2004 | US20040013647 Methods and compositions for treating a plaque-forming disease |
| 01/22/2004 | US20040013646 Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013644 Interferon beta-like molecules |
| 01/22/2004 | US20040013642 Interferon therapeutic effect-potentiating agents |
| 01/22/2004 | US20040013641 Disease prevention by reactivation of the thymus |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/22/2004 | DE10230875A1 Tubulysin-Biokonjugate Tubulysin bioconjugates |
| 01/22/2004 | DE10230874A1 Neue Tubulysinanaloga New Tubulysinanaloga |
| 01/22/2004 | DE10230872A1 Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern A process for the preparation of substituted thiazol-2-ylmethylestern |
| 01/22/2004 | DE10230752A1 Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika New pharmaceutical compositions based on magnesium salts and fibrinolytics |
| 01/22/2004 | DE10230381A1 Verwendung von Inhibitoren der Alanyl-Aminopeptidasen und diese umfassende pharmazeutischen Zubereitungen Use of inhibitors of alanyl-aminopeptidase, and pharmaceutical preparations comprising them |
| 01/22/2004 | DE10228627A1 Verfahren zur Prophylaxe und Therapie von Mykosen bei Fischen und Wirbellosen und deren Entwicklungsstadien Method for the prophylaxis and treatment of mycoses in fish and invertebrates and their stages of development |
| 01/22/2004 | DE10217035A1 Rekrutierungsmodule von RhoA und RhoC Recruitment of RhoA and RhoC modules |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493061A1 Regulatory protein for nox enzymes |
| 01/22/2004 | CA2492654A1 Human immunosuppressive protein |
| 01/22/2004 | CA2492649A1 Therapies for renal failure using interferon-.beta. |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492554A1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 01/22/2004 | CA2492485A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | CA2492355A1 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | CA2492313A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | CA2492297A1 Steroid conjugates, preparation thereof and the use thereof |
| 01/22/2004 | CA2492093A1 Topical treatment of skin diseases |
| 01/22/2004 | CA2492029A1 Transdermal botulinum toxin compositions |